Autopsy report · NCT01126255

Progesterone vs Clobetasol Propionate in Vulvar Lichen Sclerosus

“Recruitment problems”

The sponsor’s own words in the registry.

Life of this trial

• Registered 10 months before it started.
• Ran for about 3 years 4 months before it stopped.
• 37 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

Insel Gruppe AG, University Hospital Bern

Sponsor type

University, hospital or other

Conditions

Vulvar Lichen Sclerosus

Interventions

Clobetasol propionate 0.05%; Progesterone 8%

Participants

37

Sites

1

Countries

Switzerland

Trials that died the same way

• Radiochemotherapy Followed by Adjuvant Chemotherapy Based on Gemcitabine in Uterine Cervical Cancer
  “Problems of recruitment” (97% match in meaning)
• Hypoxic Conditioning in Heart Failure
  “recruitment problem” (95% match in meaning)
• Study of the Impact of Non-pharmacological Techniques on Cognitive Complaints in Cancer Patients
  “Problems with recruitment” (95% match in meaning)
• Checkpoint Blockade in COVID-19 Pandemic
  “Recruitment issues” (95% match in meaning)
• Robotic Decompression of the Pudendal Nerve in Pudendal Neuralgia
  “recruitments difficulties” (93% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.